Bae, S.; Huh, K.Y.; Oh, J.; Yu, K.-S.; Kim, A.
Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration. Pharmaceuticals 2023, 16, 132.
https://doi.org/10.3390/ph16010132
AMA Style
Bae S, Huh KY, Oh J, Yu K-S, Kim A.
Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration. Pharmaceuticals. 2023; 16(1):132.
https://doi.org/10.3390/ph16010132
Chicago/Turabian Style
Bae, Sungyeun, Ki Young Huh, Jaeseong Oh, Kyung-Sang Yu, and Anhye Kim.
2023. "Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration" Pharmaceuticals 16, no. 1: 132.
https://doi.org/10.3390/ph16010132
APA Style
Bae, S., Huh, K. Y., Oh, J., Yu, K.-S., & Kim, A.
(2023). Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration. Pharmaceuticals, 16(1), 132.
https://doi.org/10.3390/ph16010132